Gufic BioSciences Share Price

    NSE
    350.45
    +1.55 (0.57%)
    GUFICBIO • 04 Jul, 2025 | 11:48 AM
    BUY

    1Y Annualised Return

    -5.32%

    3Y Annualised Return

    16.83%

    5Y Annualised Return

    35.21%

    The current prices are delayed, login or Open Demat Account for live prices.

    Gufic BioSciences Stock Performance

    1W Return0.52
    1Y Return-4.76
    Today's Low348.1
    Prev. Close348.90
    Mkt Cap (Cr.)3,498.68
    1M Return-5.29
    3Y Return59.31
    52-Week High504.25
    Open348.90
    PE Ratio50.17
    6M Return-26.00
    Today's High353.2
    52-Week Low298.8
    Face Value1

    Gufic BioSciences Company background

    Founded in: 1984
    Managing director: Jayesh P Choksi
    Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients. Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network. The Company is ranked among the top 100 pharmaceutical companies in India.Gufic is a leading manufacturer of lyophilized injections in India, with a stateoftheart automated lyophilization plant located in Navsari, Gujarat. The Company was incorporated in July, 1984. The recent addition of the Indore manufacturing facility has further solidified Gufics position as one of the worlds largest producers of lyophilized injections. These products cover therapeutic areas, including antibiotics, antifungals, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs).The Company made a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 4042 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a longstanding presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a sellers market. The company plan to invest further in RD activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.In 202021, Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21, 2021. GUFIC UK LIMITED (GUL), a wholly owned subsidiary of the Company, was incorporated in United Kingdom on March 15, 2022. Similarly, in 2023, Gufic Ireland Limited (GIL) was incorporated on March 02, 2023.

    As of 04 Jul, 2025, Gufic BioSciences share price is ₹351. The stock opened at ₹348.9 and had closed at ₹348.9 the previous day. During today’s trading session, Gufic BioSciences share price moved between ₹348.10 and ₹353.20, with an average price for the day of ₹350.65. Over the last 52 weeks, the stock has recorded a low of ₹298.80 and a high of ₹504.25. In terms of performance, Gufic BioSciences share price has declined by 26% over the past six months and has declined by 5.32% over the last year.

    Read More
    Gufic BioSciences SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹63,29,461 (-2.62%)

    Daily SIP of 25,000 would have become 63,29,461 in 1 year with a gain of -1,70,538 (-2.62%)

    View details of Market Depth

    Gufic BioSciences Fundamental

    Market Cap (in crs)

    3,498.68

    Face Value

    1

    Turnover (in lacs)

    72.39

    Key Metrics

    Qtr Change %
    30.40% Fall from 52W High
    2
    Dividend yield 1yr %
    0.03

    Gufic BioSciences Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Gufic BioSciences Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    205.02 Cr
    207.79 Cr
    204.18 Cr
    202.81 Cr
    194.99 Cr
    Gufic BioSciences Yearly Revenue
    Mar 2025Mar 2024
    823.43 Cr
    808.84 Cr
    Gufic BioSciences Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    7.72 Cr
    19.31 Cr
    21.77 Cr
    20.86 Cr
    20.05 Cr
    Gufic BioSciences Yearly Net Profit/Loss
    Mar 2025Mar 2024
    69.65 Cr
    86.14 Cr

    Gufic BioSciences Result Highlights

    • Gufic BioSciences Ltd reported a 6.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

    • Its expenses for the quarter were down by 8.0% QoQ and - - YoY.

    • The net profit increased 3.8% QoQ and - - YoY.

    • The earnings per share (EPS) of Gufic BioSciences Ltd stood at 2 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Gufic BioSciences

    Promoter
    72.5%
    Foreign Institutions
    0.3%
    Mutual Funds
    3.4%
    Domestic Institutions
    3.4%
    Public
    23.8%
    Promoter
    72.5%
    Foreign Institutions
    0.3%
    Mutual Funds
    2.9%
    Domestic Institutions
    3%
    Public
    24.2%
    Promoter
    72.5%
    Foreign Institutions
    0.2%
    Mutual Funds
    2.5%
    Domestic Institutions
    2.5%
    Public
    24.8%
    Promoter
    72.5%
    Foreign Institutions
    0.2%
    Mutual Funds
    2.3%
    Domestic Institutions
    2.4%
    Public
    24.9%
    Promoter
    72.5%
    Foreign Institutions
    0.1%
    Mutual Funds
    2.1%
    Domestic Institutions
    2.2%
    Public
    25.2%
    Promoter
    72.5%
    Foreign Institutions
    0.5%
    Mutual Funds
    1.6%
    Domestic Institutions
    1.7%
    Public
    25.3%

    Gufic BioSciences Technical Analysis

    Moving Averages Analysis
    350.45
    Current Price
    Bullish Moving Averages
    0
    Bearish Moving Averages
    16
    5Day EMA
    352.00
    10Day EMA
    354.30
    12Day EMA
    355.30
    20Day EMA
    358.80
    26Day EMA
    360.50
    50Day EMA
    363.90
    100Day EMA
    371.30
    200Day EMA
    375.50
    5Day SMA
    353.20
    10Day SMA
    352.10
    20Day SMA
    360.50
    30Day SMA
    366.50
    50Day SMA
    368.60
    100Day SMA
    362.70
    150Day SMA
    390.00
    200Day SMA
    397.10
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    26342 Rs
    43182 Rs
    Week Rs
    28793 Rs
    59180 Rs
    Month Rs
    23216 Rs
    44077 Rs
    349.70
    Pivot
    Resistance
    First Resistance
    353.10
    Second Resistance
    357.30
    Third Resistance
    360.70
    Support
    First Support
    345.50
    Second support
    342.10
    Third Support
    337.90
    Relative Strength Index
    40.33
    Money Flow Index
    51.69
    MACD
    -5.23
    MACD Signal
    -4.34
    Average True Range
    11.78
    Average Directional Index
    14.70
    Rate of Change (21)
    -5.84
    Rate of Change (125)
    -23.58
    Name
    Holding Percent
    Motilal Oswal Small Cap Fund
    1.38

    Gufic BioSciences Latest News

    02 JUL 2025 | Wednesday

    Gufic Biosciences Ltd - 509079 - Appointment Of Senior Management Personnel - Mr. Rajesh Kaul As Senior President - Sparsh Cluster

    30 JUN 2025 | Monday

    Gufic Biosciences Ltd - 509079 - Resignation Of Senior Management Personnel

    27 JUN 2025 | Friday

    Gufic Biosciences Ltd - 509079 - Closure of Trading Window

    View More

    Gufic BioSciences Share Price FAQs

    Gufic BioSciences share price is ₹350.45 in NSE and ₹350.9 in BSE as on 4/7/2025.

    Gufic BioSciences share price in the past 1-year return was -4.76. The Gufic BioSciences share hit a 1-year low of Rs. 298.8 and a 1-year high of Rs. 504.25.

    The market cap of Gufic BioSciences is Rs. 3498.68 Cr. as of 4/7/2025.

    The PE ratios of Gufic BioSciences is 50.17 as of 4/7/2025.

    The PB ratios of Gufic BioSciences is 5.83 as of 4/7/2025

    The Mutual Fund Shareholding in Gufic BioSciences was 3.39% at the end of 4/7/2025.

    You can easily buy Gufic BioSciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Gufic BioSciences share price is ₹504.25 and ₹298.8 as of 4/7/2025.

    Please be aware that Gufic BioSciences stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.39
    +0.12 (+0.18%)
    139.79
    +0.09 (+0.06%)
    690.30
    -0.10 (-0.01%)
    2,606.60
    -4.60 (-0.18%)
    167.70
    +0.18 (+0.11%)
    392.35
    +1.70 (+0.44%)
    163.99
    -1.92 (-1.16%)
    263.10
    +2.25 (+0.86%)
    430.00
    +3.75 (+0.88%)
    401.90
    +2.00 (+0.50%)
    Top Gainers
    927.45
    +17.30 (+1.90%)
    4,349.40
    +38.80 (+0.90%)
    1,993.90
    +13.20 (+0.67%)
    1,516.90
    +8.20 (+0.54%)
    2,324.90
    +11.50 (+0.50%)
    Top Losers
    5,572.00
    -619.00 (-10.00%)
    163.04
    -2.87 (-1.73%)
    5,631.00
    -85.00 (-1.49%)
    1,786.90
    -23.30 (-1.29%)
    1,034.30
    -11.80 (-1.13%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -